Article info
PDFBasic research
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
- Correspondence to:
Dr med Dirk Reinhardt, Department of Internal Medicine, University of Jena, Erlanger Allee 101, D-07740 Jena, Germany;
dirk.reinhardt{at}med.uni-jena.de
Citation
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
Publication history
- Accepted July 4, 2002
- First published November 1, 2002.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Heart